EXHIBIT 11.1 NEUROGEN CORPORATION COMPUTATION OF NET INCOME (LOSS) PER COMMON SHARE (in thousands, except Net Income (Loss) per Common Share amounts) THREE MONTHS THREE MONTHS SIX MONTHS SIX MONTHS ENDED ENDED ENDED ENDED JUNE 30, 1997 JUNE 30, 1996 JUNE 30, 1997 JUNE 30, 1996 (UNAUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) ----------- ----------- ----------- ---------- Primary: Weighted average shares of common stock outstanding 14,339 14,141 14,313 14,081 Dilutive effect of : Warrants (1) 43 36 43 Stock options (1) 1,349 996 1,412 ------------ ------------ ------------ --------------- Common and common equivalent shares 14,339 15,533 15,345 15,536 ============ ============ ============ =============== Net income (loss) $ (255) $ 1,118 $ 2,595 $ 4,728 ============ ============ ============ =============== Earnings (loss) per common and common equivalent shares $ (0.02) $ 0.07 $ 0.17 $ 0.30 ============ ============ ============ =============== Fully Diluted: Weighted average shares of common stock outstanding 14,339 14,141 14,313 14,081 Dilutive effect of : Warrants (1) 43 36 43 Stock options (1) 1,349 1,098 1,412 ------------ ------------ ------------ --------------- Common and common equivalent shares 14,339 15,533 15,447 15,536 ============ ============ ============ =============== Net income (loss) $ (255) $ 1,118 $ 2,595 $ 4,728 ============ ============ ============ =============== Earnings (loss) per common and common equivalent shares $ (0.02) $ 0.07 $ 0.17 $ 0.30 ============ ============ ============ =============== (1) The Common Stock Equivalents have not been included as their inclusion would be antidilutive.